Mainz Biomed B.V. Profile Avatar - Palmy Investing

Mainz Biomed B.V.

Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product ca…

Medical - Diagnostics & Research
DE, Mainz [HQ]
Major Shareholders · Proxy Ben. Owners

Shareholders

Breakdown
Institutional
Insider
Retail
0.56%
20.22%
79.22%
Intraday
Shares Outstanding
2,221,596
Volume
145,092
Volume on Avg.
2,563,627
Beneficial Owners Beta
SEC Source
Owner Shares Equivalence - $5.00 per share Last Form/Filing Last Transaction
10% Holder
- No data -
Officers/Directors Below 10%
- No data -
End of MYNZ's Analysis
CIK: 1874252 CUSIP: N5436L101 ISIN: NL0015000LC2 LEI: - UEI: -
Secondary Listings
MYNZ has no secondary listings inside our databases.